Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Inks Collaboration with University of Birmingham for Proteomic, Metabolomic Research

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said yesterday that it has formed a technology alliance with the University of Birmingham, UK.

Under the partnership, the company will work with university researchers on high-resolution accurate mass and triple quadrupole liquid chromatography mass spectrometry for applications in proteomics and metabolomics.

Birmingham researcher Helen Cooper will lead the proteomics work, which will focus on using high-resolution mass spec and gas-phase ion chemistry for top-down and bottom-up analysis of proteins.

The metabolomics efforts will be led by Birmingham professors Mark Viant and Warwick Dunn and will aim to develop and test new hardware and software approaches for metabolite detection and identification in environmental and clinical research.

With the signing of the agreement, the university becomes Thermo Fisher's first Technology Alliance partner in Europe.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.